Lung cancer: New surgical approaches

Respirology

Volumn 12, Issue 3, 2007, Pages 326-332

  Sherwood, J Timothy ^a   Brock, Malcolm V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CHEMOSENSITIVITY; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC SURGERY; HUMAN; INCISION; LUNG CANCER; LUNG LOBECTOMY; MULTIMODALITY CANCER THERAPY; OPERATING ROOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SCREENING; SURGICAL TECHNIQUE; ULTRASOUND; CATHETER ABLATION; LUNG SURGERY; LUNG TUMOR; METHODOLOGY; PATHOLOGY; THORAX SURGERY;

CATHETER ABLATION; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PULMONARY SURGICAL PROCEDURES; THORACIC SURGERY, VIDEO-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547416098     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01083.x     Document Type: Review

References (40)

1. Hellman S. Stopping metastases at their source. N. Engl. J. Med. 1997 337 : 996 7.
2. Riethmuller G, Johnson JP. Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr. Opin. Immunol. 1992 4 : 647 55.
3. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur. J. Cancer 1997 33 : 1075 107.
4. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J. Thorac. Cardiovasc. Surg. 1995 109 : 120 9.
5. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997 111 : 1710 17.
6. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet 2000 355 : 479 85.
7. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999 354 : 99 105.
8. Sone S, Li F, Yang ZG, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br. J. Cancer 2001 84 : 25 32.
9. Diederich S, Wormanns D, Semik M, et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002 222 : 773 81.
10. Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002 122 : 15 20.
11. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am. J. Respir. Crit. Care Med. 2002 165 : 508 13.
12. Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J. Clin. Oncol. 2002 20 : 911 20.
13. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N. Engl. J. Med. 2006 355 : 1763 71.
14. Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR. Lung cancer screening with helical computed tomography in older adult smokers. a decision and cost-effectiveness analysis. JAMA 2003 289 : 313 22.
15. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N. Engl. J. Med. 2003 348 : 2500 7.
16. Cheran SK, Herndon JE 2nd, Patz EF Jr. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 2004 44 : 317 25.
17. Reed CE, Harpole DH, Posther KE, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2003 126 : 1943 51.
18. Kernstine KH, McLaughlin KA, Menda Y, et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Ann. Thorac. Surg. 2002 73 : 394 401 discussion 401 2.
19. Gonzalez-Stawinski GV, Lemaire A, Merchant F, et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2003 126 : 1900 5.
20. Luke WP, Pearson FG, Todd TR, Patterson GA, Cooper JD. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J. Thorac. Cardiovasc. Surg. 1986 91 : 53 6.
21. Coughlin M, Deslauriers J, Beaulieu M, et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann. Thorac. Surg. 1985 40 : 556 60.
22. Witte B, Wolf M, Huertgen M, Toomes H. Video-assisted mediastinoscopic surgery: clinical feasibility and accuracy of mediastinal lymph node staging. Ann. Thorac. Surg. 2006 82 : 1821 7.
23. Venissac N, Alifano M, Mouroux J. Video-assisted mediastinoscopy: experience from 240 consecutive cases. Ann. Thorac. Surg. 2003 76 : 208 12.
24. Goldstraw P, Mannam GC, Kaplan DK, Michail P. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J. Thorac. Cardiovasc. Surg. 1994 107 : 19 27 discussion 27 8.
25. Cerfolio RJ, Bryant AS, Eloubeidi MA. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest 2006 130 : 1791 5.
26. Madar I, Lesser RP, Krauss G, et al. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Ann. Neurol. 1997 41 : 358 67.
27. Bencherif B, Fuchs PN, Sheth R, Dannals RF, Campbell JN, Frost JJ. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET). Pain 2002 99 : 589 98.
28. Yasufuku K, Nakajima T, Motoori K, et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 2006 130 : 710 18.
29. Ginsberg RJ, Hill LD, Eagan RT, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J. Thorac. Cardiovasc. Surg. 1983 86 : 654 8.
30. Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N. Engl. J. Med. 2006 355 : 570 80.
31. Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N. Engl. J. Med. 2007 356 : 11 20.
32. Nomori H, Horio H, Naruke T, Suemasu K. What is the advantage of a thoracoscopic lobectomy over a limited thoracotomy procedure for lung cancer surgery? Ann. Thorac. Surg. 2001 72 : 879 84.
33. Nagahiro I, Andou A, Aoe M, Sano Y, Date H, Shimizu N. Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure. Ann. Thorac. Surg. 2001 72 : 362 5.
34. McKenna RJ Jr., Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann. Thorac. Surg. 2006 81 : 421 5 discussion 425 6.
35. Gharagozloo F, Tempesta B, Margolis M, Alexander EP. Video-assisted thoracic surgery lobectomy for stage I lung cancer. Ann. Thorac. Surg. 2003 76 : 1009 14 discussion 1014 15.
36. Brock MV. Neoadjuvant and adjuvant therapy of esophageal cancer. In : Cameron J (ed.) Current Surgical Therapy. Mosby, Philadelphia, PA, 2004.
37. McKenna RJ Jr, Wolf RK, Brenner M, Fischel RJ, Wurnig P. Is lobectomy by video-assisted thoracic surgery an adequate cancer operation? Ann. Thorac. Surg. 1998 66 : 1903 8.
38. Shiraishi T, Shirakusa T, Hiratsuka M, Yamamoto S, Iwasaki A. Video-assisted thoracoscopic surgery lobectomy for c-T1N0M0 primary lung cancer: its impact on locoregional control. Ann. Thorac. Surg. 2006 82 : 1021 6.
39. Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006 129 : 738 45.
40. Donington JSSL, Loo B, Wakelee H, Whyte R, Le Q. Single Fraction Stereotactic Radiosurgery (SFSR) for the Treatment of Stage 1 Non-Small cell Lung Cancer (NSCLC). San Diego, CA, 2007.